Transition Bio, Inc. is a biotechnology company that specializes in the discovery, analysis, and modulation of biological condensates. Established in 2020 and headquartered in Cambridge, Massachusetts, with an additional office in Cambridge, United Kingdom, the company has developed a unique platform known as Condensomics. This hypothesis-free drug discovery and diagnostics technology allows for expansive opportunities in drug development by leveraging the intricate properties of biological condensates. Transition Bio's innovative approach aims to advance the understanding and application of these biological structures in the field of medicine.
MindRight Health, founded in 2019 and based in Newark, New Jersey, offers mental health coaching through text messages, aiming to make mental health care accessible and inclusive for communities of color and low-income families. The company provides a personalized coaching system that matches users with specific coaches, delivering culturally-responsive support seven days a week. MindRight's services address the unique challenges faced by youth who often avoid traditional clinical services due to stigma and accessibility issues. By partnering with healthcare payers and providers, MindRight creates a continuum of support that helps predict and prevent mental health crises in these communities. Coaches engage with users by checking in regularly and tracking their progress, ensuring effective mental health assistance tailored to their needs.
Biopharmaceutical research and development company that's an affiliate of Clover Health
Aspen Neuroscience, Inc. is a biotechnology company based in San Diego, California, focused on developing induced pluripotent stem cell therapies for neurological conditions, particularly Parkinson's disease. Founded in 2018, the company aims to create patient-specific restorative cell therapies that can alter the progression of the disease. Its product pipeline includes ANPD001, an autologous neuron replacement therapy designed for sporadic Parkinson's disease, and ANPD002, a gene-edited version targeting familial forms of the disease. By integrating innovative genomic approaches with stem cell biology, Aspen Neuroscience seeks to advance the field of personalized medicine and improve treatment outcomes for patients suffering from Parkinson's disease.
Vivante Health, Inc. is a digital health company focused on addressing digestive health and chronic conditions. Founded in 2016, it has developed GIThrive, a technology platform designed to provide actionable insights for managing digestive issues. GIThrive offers a comprehensive digital gut health program that includes expert guidance, 24/7 support, and personalized care plans. The company also provides GIMate, an innovative portable breathalyzer that identifies trigger foods, and GutCheck, which analyzes gut bacteria to recommend tailored diets. Vivante Health emphasizes individualized care, utilizing a scalable platform that integrates real-time data from biometric devices and partners. This approach not only aims to reduce healthcare costs and improve employee health for large employers and health plans but also enhances user empowerment through advanced science and technology. Headquartered in Houston, Texas, with an additional office in Athens, Greece, Vivante Health continues to prioritize innovative solutions in the realm of digestive health.
Synapticure is a tele neurology startup focused on providing customized care for patients with Amyotrophic Lateral Sclerosis (ALS) and their families. The company operates a virtual clinical care platform that leverages advances in science and technology to identify and treat each patient's specific needs. Through this platform, patients gain easy access to neurologists and comprehensive behavioral health services, including psychiatry and therapy care coordination, all integrated into one system. This approach aims to enhance the patient experience by ensuring that they receive the necessary support and resources while managing their condition from the comfort of their homes.
64x Bio is a biotechnology company based in San Francisco, California, founded in 2017 by Alexis Rovner, George Church, Jeffrey Way, and Pamela Silver. The company specializes in designing microorganisms with enhanced properties to facilitate advanced applications in biomanufacturing, bioremediation, and health. By creating cells tailored for specific purposes, 64x Bio aims to enable innovative solutions that were previously unattainable in these fields.
PostEra is a company based in Santa Clara, California, that specializes in medicinal chemistry services by combining molecular design with chemical synthesis. Founded in 2019, it leverages machine learning algorithms to streamline the drug discovery process, significantly reducing cycle times for its clients. The platform automates traditional manual methods, allowing for the iterative refinement of drug candidates, prediction of manufacturing techniques, and optimization of experimental testing. By addressing challenges in chemical reaction predictions and bioactivity assessments, PostEra aims to enhance the efficiency and safety of drug development. The company is actively involved in an international initiative to discover antiviral treatments for COVID-19 through open science collaboration.
Verge Genomics focuses on accelerating drug discovery for neurodegenerative diseases through the use of artificial intelligence and genomic data. The company has developed a platform that leverages machine learning to analyze large datasets, identifying genetic targets and predicting effective therapeutics. By mapping genes associated with various neurodegenerative conditions, Verge aims to discover drugs that can simultaneously target multiple genetic factors. Founded by experts in machine learning and neuroscience, Verge Genomics seeks to improve patient outcomes and reduce the costs associated with pharmaceutical development. The company is based in Mountain View, California, and has formed a strategic alliance with Datavant to enhance its data-driven approach.
Mythic Therapeutics is a biotechnology company focused on a new generation of groundbreaking cancer therapeutics. The company is pioneering a powerful protein engineering-focused approach to improving the effectiveness of antibody-drug conjugates (ADCs) and other antibody-based therapeutics. Their technology dramatically increases therapeutic potency without compromising safety, thereby unlocking the full potential of targeted therapies against a broad array of tumor targets. Mythic Therapeutics was founded in 2017 and is headquartered in Waltham, MA, USA.
Fauna Bio is developing new ways to treat human diseases, such as heart disease and neurodegenerative disease, by adopting mechanisms animals have developed for traits such as hibernation and deep-diving. Founded by three scientists who have intimate knowledge of the best science and resources from the field of non-model organisms, Fauna Bio leverages data from hundreds of species in order to help develop pre-clinical and early clinical testing for new therapeutics targeting human diseases.
Sonoma Biotherapeutics develops adoptive Treg cell therapies aimed at treating autoimmune and degenerative diseases. The company employs advanced genome editing and target-specific cell therapy to create therapeutic solutions that promote self-tolerance and mitigate harmful inflammatory responses associated with conditions such as rheumatoid arthritis, inflammatory bowel disease, multiple sclerosis, amyotrophic lateral sclerosis, and Alzheimer's disease. Founded in 2019 and headquartered in South San Francisco, California, with an additional office in Seattle, Washington, Sonoma Biotherapeutics combines expertise in Treg biology and proprietary methodologies to advance its therapeutic platform, focusing on developing disease-modifying and potentially curative treatments.
Bayesian Health Inc., a digital health company, provides an AI-driven platform that monitors patients illness severity, detecting changes in acuity, and augments provider decision-making to optimize care throughout their hospital stay. Its platform enables clinical staff and hospital leadership to make timely decisions in complex clinical areas. The company was incorporated in 2016 and is based in New York, New York.
Enveda Therapeutics is constructing and decoding the largest integrated dataset of anthropological, biological, and chemical information from medicinal plants to inspire new medicines.
Sempre Health, Inc. owns and operates a platform and offers behavior-based healthcare pricing to healthcare industry. The company works with health plans and pharmaceutical manufacturers to dynamically adjust a patient's co-payment based on individual adherence and behavior. It parses prescription records to predict the right price based on the patient's adherence to taking medicines in time. The company provides the patients access to their current discounts, why they got those discounts, and guidance on how to improve their health, via SMS. The company was founded in 2015 and is based in San Francisco, California.
Wren Therapeutics Limited is a biopharmaceutical company based in Cambridge, United Kingdom, focused on the development of small molecule therapeutics for protein misfolding diseases. Founded in 2016, the company aims to address major neurological conditions, such as Alzheimer’s and Parkinson’s diseases, as well as rare disorders like amyloidosis and type-2 diabetes. Wren's proprietary technology platform is grounded in extensive scientific research from the University of Cambridge and Lund University, providing a novel understanding of the origins of these diseases. The company specializes in drug discovery and the clinical translation of therapeutic molecules, contributing to advancements in the diagnosis and treatment of various conditions related to protein misfolding.
Sitka, Inc. is a technology company that operates an online communication platform designed to connect patients with healthcare providers across various specialties, including endocrinology, neurology, orthopedics, pulmonology, and rheumatology. Founded in 2018 by experts in healthcare, the platform emphasizes the upskilling of primary care providers and aims to enhance the specialty care experience in the United States. Sitka facilitates personalized consultations, allowing patients to receive tailored advice and recommendations from board-certified specialists based on their medical conditions and diagnostic results. By streamlining communication and fostering patient inclusion, Sitka seeks to improve care delivery and ensure that all patients receive informed and effective treatment. The company is headquartered in Carmel, California, and has received backing from several prominent investors in the healthcare sector.
Transition Bio, Inc. is a biotechnology company that specializes in the discovery, analysis, and modulation of biological condensates. Established in 2020 and headquartered in Cambridge, Massachusetts, with an additional office in Cambridge, United Kingdom, the company has developed a unique platform known as Condensomics. This hypothesis-free drug discovery and diagnostics technology allows for expansive opportunities in drug development by leveraging the intricate properties of biological condensates. Transition Bio's innovative approach aims to advance the understanding and application of these biological structures in the field of medicine.
Vineti is a commercial cloud-based platform that expands patient access to life-saving cells and gene therapies.
The software solution offers an independent, purpose-built enterprise solution that is essential for enabling the growth and wide distribution of transformative personalized therapeutics, such as CAR-T cell therapies, for the treatment of late-stage cancer. The Vineti Personalized Therapy Management (PTM) ® platform automates patient-centric supply chains for a wide range of advanced therapies, in all phases of clinical development and commercial operations. Veneti aims to solve the key challenges patients, medical providers, pharmaceutical companies, and regulators face in the delivery and commercialization of personalized medicine.
Amy DuRoss, Heidi M. Hagen, Malek Faham, Razmik Abnous, and Stephen Ting co-founded Vineti in San Francisco, California in 2016.
Sonoma Biotherapeutics develops adoptive Treg cell therapies aimed at treating autoimmune and degenerative diseases. The company employs advanced genome editing and target-specific cell therapy to create therapeutic solutions that promote self-tolerance and mitigate harmful inflammatory responses associated with conditions such as rheumatoid arthritis, inflammatory bowel disease, multiple sclerosis, amyotrophic lateral sclerosis, and Alzheimer's disease. Founded in 2019 and headquartered in South San Francisco, California, with an additional office in Seattle, Washington, Sonoma Biotherapeutics combines expertise in Treg biology and proprietary methodologies to advance its therapeutic platform, focusing on developing disease-modifying and potentially curative treatments.
Sonoma Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops and markets stabilized hypochlorous acid (HOCl) products for a range of healthcare applications, including wound care, dermatology, animal health, and eye care. The company offers a diverse portfolio of products designed to address various medical needs, such as Epicyn, an antimicrobial facial cleanser; Levicyn, for managing dermatoses; and Celacyn, which promotes healing of surgical scars and trauma wounds. Other notable products include SebuDerm for seborrheic dermatitis, Ceramax for dry skin, and Acuicyn for eye irritation. Sonoma also provides solutions for animal health, like MicrocynAH and MicrocynVS, targeting skin conditions in pets. With over 100 products commercialized globally across 33 countries, the company aims to enhance patient care while addressing unmet medical needs and reducing healthcare costs. Founded in 1999 and based in Woodstock, Georgia, Sonoma Pharmaceuticals was previously known as Oculus Innovative Sciences, Inc. before rebranding in 2016.
TARA Biosystems, Inc. is a biotechnology company focused on developing organ-on-a-chip technology, specifically human cardiac tissue models, to enhance drug discovery and safety assessments. Founded in 2014 and based in the United States, the company utilizes stem cell-derived cardiac tissue that mimics adult physiological conditions, enabling precise measurement of cardiac functionality. This innovative platform aims to facilitate the faster and safer development of new therapies by providing predictive in vitro models that can assess the effects of drug compounds on heart function without the need for human testing. Through its advanced technology, TARA Biosystems seeks to improve the health of patients by enabling more reliable assessments of cardiac drug efficacy and safety.
Biopharmaceutical research and development company that's an affiliate of Clover Health
Circle Pharma, Inc. is an early-stage biotechnology company based in South San Francisco, California, focused on developing cell-permeable macrocyclic peptide therapeutics. Founded in 2012 by Professors Matt Jacobson and Scott Lokey, the company utilizes proprietary computational design algorithms and innovative synthetic chemistry to create macrocycles targeting significant clinical challenges. Their approach involves an iterative design process that leverages large virtual libraries of diverse macrocycle scaffolds, selected for their permeability. Circle Pharma aims to address unmet clinical needs, particularly in the treatment of cancer, by focusing on intracellular protein-protein interactions through its novel macrocycle therapies, which can be delivered via multiple routes, including oral administration. The company's work is intended to enable healthcare professionals to advance internal development efforts in this critical area of medicine.
Vineti is a commercial cloud-based platform that expands patient access to life-saving cells and gene therapies.
The software solution offers an independent, purpose-built enterprise solution that is essential for enabling the growth and wide distribution of transformative personalized therapeutics, such as CAR-T cell therapies, for the treatment of late-stage cancer. The Vineti Personalized Therapy Management (PTM) ® platform automates patient-centric supply chains for a wide range of advanced therapies, in all phases of clinical development and commercial operations. Veneti aims to solve the key challenges patients, medical providers, pharmaceutical companies, and regulators face in the delivery and commercialization of personalized medicine.
Amy DuRoss, Heidi M. Hagen, Malek Faham, Razmik Abnous, and Stephen Ting co-founded Vineti in San Francisco, California in 2016.
Vivante Health, Inc. is a digital health company focused on addressing digestive health and chronic conditions. Founded in 2016, it has developed GIThrive, a technology platform designed to provide actionable insights for managing digestive issues. GIThrive offers a comprehensive digital gut health program that includes expert guidance, 24/7 support, and personalized care plans. The company also provides GIMate, an innovative portable breathalyzer that identifies trigger foods, and GutCheck, which analyzes gut bacteria to recommend tailored diets. Vivante Health emphasizes individualized care, utilizing a scalable platform that integrates real-time data from biometric devices and partners. This approach not only aims to reduce healthcare costs and improve employee health for large employers and health plans but also enhances user empowerment through advanced science and technology. Headquartered in Houston, Texas, with an additional office in Athens, Greece, Vivante Health continues to prioritize innovative solutions in the realm of digestive health.
Notable Labs, Inc. develops and operates a platform that provides lab testing services for brain cancer patients. The company runs drug combination experiments on the tumor and gives a report back to the patient’s doctor. Notable Labs, Inc. was formerly known as StemCycle, Inc. The company was incorporated in 2014 and is based in Foster City, California.
Notable Labs, Inc. develops and operates a platform that provides lab testing services for brain cancer patients. The company runs drug combination experiments on the tumor and gives a report back to the patient’s doctor. Notable Labs, Inc. was formerly known as StemCycle, Inc. The company was incorporated in 2014 and is based in Foster City, California.
Wren Therapeutics Limited is a biopharmaceutical company based in Cambridge, United Kingdom, focused on the development of small molecule therapeutics for protein misfolding diseases. Founded in 2016, the company aims to address major neurological conditions, such as Alzheimer’s and Parkinson’s diseases, as well as rare disorders like amyloidosis and type-2 diabetes. Wren's proprietary technology platform is grounded in extensive scientific research from the University of Cambridge and Lund University, providing a novel understanding of the origins of these diseases. The company specializes in drug discovery and the clinical translation of therapeutic molecules, contributing to advancements in the diagnosis and treatment of various conditions related to protein misfolding.
Vivante Health, Inc. is a digital health company focused on addressing digestive health and chronic conditions. Founded in 2016, it has developed GIThrive, a technology platform designed to provide actionable insights for managing digestive issues. GIThrive offers a comprehensive digital gut health program that includes expert guidance, 24/7 support, and personalized care plans. The company also provides GIMate, an innovative portable breathalyzer that identifies trigger foods, and GutCheck, which analyzes gut bacteria to recommend tailored diets. Vivante Health emphasizes individualized care, utilizing a scalable platform that integrates real-time data from biometric devices and partners. This approach not only aims to reduce healthcare costs and improve employee health for large employers and health plans but also enhances user empowerment through advanced science and technology. Headquartered in Houston, Texas, with an additional office in Athens, Greece, Vivante Health continues to prioritize innovative solutions in the realm of digestive health.
Cricket Health Inc., founded in 2015 and based in San Francisco, California, specializes in integrated nephrology and dialysis care for individuals with Chronic Kidney Disease (CKD) and End Stage Renal Disease (ESRD). The company offers a technology-enabled, multidisciplinary approach to kidney care, delivering both in-person and virtual services aimed at improving patient outcomes and reducing hospitalizations. By identifying at-risk patients and intervening early, Cricket Health focuses on slowing disease progression and providing personalized care options, which include transplant support, home dialysis, and in-center dialysis. The company's commitment extends to aligning its success with that of its partners and the patients it serves, ultimately striving to enhance the quality of life for those affected by kidney disease.
Sempre Health, Inc. owns and operates a platform and offers behavior-based healthcare pricing to healthcare industry. The company works with health plans and pharmaceutical manufacturers to dynamically adjust a patient's co-payment based on individual adherence and behavior. It parses prescription records to predict the right price based on the patient's adherence to taking medicines in time. The company provides the patients access to their current discounts, why they got those discounts, and guidance on how to improve their health, via SMS. The company was founded in 2015 and is based in San Francisco, California.
Verge Genomics focuses on accelerating drug discovery for neurodegenerative diseases through the use of artificial intelligence and genomic data. The company has developed a platform that leverages machine learning to analyze large datasets, identifying genetic targets and predicting effective therapeutics. By mapping genes associated with various neurodegenerative conditions, Verge aims to discover drugs that can simultaneously target multiple genetic factors. Founded by experts in machine learning and neuroscience, Verge Genomics seeks to improve patient outcomes and reduce the costs associated with pharmaceutical development. The company is based in Mountain View, California, and has formed a strategic alliance with Datavant to enhance its data-driven approach.
Sitka, Inc. is a technology company that operates an online communication platform designed to connect patients with healthcare providers across various specialties, including endocrinology, neurology, orthopedics, pulmonology, and rheumatology. Founded in 2018 by experts in healthcare, the platform emphasizes the upskilling of primary care providers and aims to enhance the specialty care experience in the United States. Sitka facilitates personalized consultations, allowing patients to receive tailored advice and recommendations from board-certified specialists based on their medical conditions and diagnostic results. By streamlining communication and fostering patient inclusion, Sitka seeks to improve care delivery and ensure that all patients receive informed and effective treatment. The company is headquartered in Carmel, California, and has received backing from several prominent investors in the healthcare sector.
Vineti is a commercial cloud-based platform that expands patient access to life-saving cells and gene therapies.
The software solution offers an independent, purpose-built enterprise solution that is essential for enabling the growth and wide distribution of transformative personalized therapeutics, such as CAR-T cell therapies, for the treatment of late-stage cancer. The Vineti Personalized Therapy Management (PTM) ® platform automates patient-centric supply chains for a wide range of advanced therapies, in all phases of clinical development and commercial operations. Veneti aims to solve the key challenges patients, medical providers, pharmaceutical companies, and regulators face in the delivery and commercialization of personalized medicine.
Amy DuRoss, Heidi M. Hagen, Malek Faham, Razmik Abnous, and Stephen Ting co-founded Vineti in San Francisco, California in 2016.
Senti Biosciences is a clinical-stage biotechnology company based in South San Francisco, California, focused on developing innovative gene and cell therapies using its proprietary synthetic biology platform. Founded in 2016, the company aims to address complex diseases through advanced therapeutic solutions. Senti's technology includes engineered allogeneic chimeric antigen receptor natural killer (CAR-NK) cells, which are designed to target and eliminate cancer cells while minimizing damage to healthy tissue. Among its product candidates are SENTI-202, a Logic Gated CAR-NK cell therapy intended for cancer treatment, and SENTI-301A, which targets hepatocellular carcinoma. Senti Biosciences operates as a resident company at Johnson & Johnson Innovation's JLABS in South San Francisco, collaborating with experts in synthetic biology and computation to advance its therapeutic developments.
Floreo Inc. is a Washington, D.C.-based startup established in 2016 that focuses on developing a virtual reality application aimed at teaching social and communication skills to individuals with autism spectrum disorder. The app provides a safe and engaging environment for users, allowing them to engage in therapy that is immersive and repeatable. Supervising adults can monitor and guide the activities while tracking the user's progress. Floreo is currently piloting its application at a special education school, a large ABA therapy company, and in collaboration with the Center for Autism Research at Children's Hospital of Philadelphia. The company emphasizes the importance of a science-backed product and has formed partnerships with leading research, academic, therapy, and civic organizations to enhance its offerings.
Notable Labs, Inc. develops and operates a platform that provides lab testing services for brain cancer patients. The company runs drug combination experiments on the tumor and gives a report back to the patient’s doctor. Notable Labs, Inc. was formerly known as StemCycle, Inc. The company was incorporated in 2014 and is based in Foster City, California.
Vineti is a commercial cloud-based platform that expands patient access to life-saving cells and gene therapies.
The software solution offers an independent, purpose-built enterprise solution that is essential for enabling the growth and wide distribution of transformative personalized therapeutics, such as CAR-T cell therapies, for the treatment of late-stage cancer. The Vineti Personalized Therapy Management (PTM) ® platform automates patient-centric supply chains for a wide range of advanced therapies, in all phases of clinical development and commercial operations. Veneti aims to solve the key challenges patients, medical providers, pharmaceutical companies, and regulators face in the delivery and commercialization of personalized medicine.
Amy DuRoss, Heidi M. Hagen, Malek Faham, Razmik Abnous, and Stephen Ting co-founded Vineti in San Francisco, California in 2016.
Clover Health is a health insurance company that specializes in providing Medicare Advantage plans for senior citizens. Founded in 2014 and headquartered in San Francisco, California, the company also has offices in several states, including New Jersey, Arizona, Georgia, Pennsylvania, South Carolina, Tennessee, and Texas. Clover Health operates a Preferred Provider Organization (PPO) platform that aims to enhance the quality of life for its members through patient-centered analytics and dedicated care management. By utilizing advanced analytics and custom software, Clover Health directs its clinical staff to proactively address gaps in care, focusing on preventive measures and chronic disease management. Its approach not only aims to improve health outcomes but also seeks to reduce unnecessary healthcare spending. The company primarily generates revenue through its insurance segment, which offers both PPO and Health Maintenance Organization (HMO) plans.
Circle Pharma, Inc. is an early-stage biotechnology company based in South San Francisco, California, focused on developing cell-permeable macrocyclic peptide therapeutics. Founded in 2012 by Professors Matt Jacobson and Scott Lokey, the company utilizes proprietary computational design algorithms and innovative synthetic chemistry to create macrocycles targeting significant clinical challenges. Their approach involves an iterative design process that leverages large virtual libraries of diverse macrocycle scaffolds, selected for their permeability. Circle Pharma aims to address unmet clinical needs, particularly in the treatment of cancer, by focusing on intracellular protein-protein interactions through its novel macrocycle therapies, which can be delivered via multiple routes, including oral administration. The company's work is intended to enable healthcare professionals to advance internal development efforts in this critical area of medicine.
Circle Pharma, Inc. is an early-stage biotechnology company based in South San Francisco, California, focused on developing cell-permeable macrocyclic peptide therapeutics. Founded in 2012 by Professors Matt Jacobson and Scott Lokey, the company utilizes proprietary computational design algorithms and innovative synthetic chemistry to create macrocycles targeting significant clinical challenges. Their approach involves an iterative design process that leverages large virtual libraries of diverse macrocycle scaffolds, selected for their permeability. Circle Pharma aims to address unmet clinical needs, particularly in the treatment of cancer, by focusing on intracellular protein-protein interactions through its novel macrocycle therapies, which can be delivered via multiple routes, including oral administration. The company's work is intended to enable healthcare professionals to advance internal development efforts in this critical area of medicine.
Second Genome’s mission is to transform lives with medicines developed through innovative microbiome science. Second Genome has built a novel platform for microbiome drug discovery. Second Genome has completed more than 400 microbiome studies, analyzing more than 75,000 samples, for internal R&D, as well as for external partners across government, academia, pharmaceutical, nutrition and industrial companies. The team leverages its microbiome analysis platform with its partners’ specific expertise to generate insightful findings that can accelerate research programs by elucidating the role of the microbiome in human health conditions, agriculture, animal health and other industries. The company has established a pipeline of therapeutic products for the treatment of inflammation and metabolic diseases.
Advantia Health, LLC is a healthcare delivery company focused on providing comprehensive services to women and their families. Founded in 2014 and headquartered in Arlington, Virginia, Advantia Health offers a range of services including obstetrics, gynecology, primary care, and mental wellness, with additional locations in Virginia, Maryland, Illinois, and Missouri. The company emphasizes high-quality and efficient care through the use of technology and well-designed outpatient facilities. Advantia Health also provides telehealth services, allowing patients to connect with healthcare providers via a web and mobile application, ensuring timely access to the right care in the appropriate setting.
Dr.Consulta is a healthtech platform and primary care provider based in Brazil, focused on delivering quality medical care at an affordable cost. The company operates a network of healthcare clinics that offer outpatient services through scheduled appointments, consultations, and examinations for various medical issues, including gynecology and pediatrics. By enabling users to book appointments with healthcare professionals, Dr.Consulta aims to eliminate medically homelessness and ensure access to essential healthcare services for all.
Grand Rounds, Inc. is an employee health benefit company that specializes in healthcare navigation and expert medical opinion services. Founded in 2011 and based in San Francisco, California, with additional offices in Lewiston, Maine, and Reno, Nevada, the company partners with employers to enhance health outcomes and lower costs by guiding employees to personalized care throughout their healthcare journey. Utilizing a sophisticated matching engine, Grand Rounds identifies the most suitable doctors within users' networks to address their specific needs. The company's technology leverages machine learning and clinical research to simplify the healthcare experience, enabling employees to navigate their care effectively. By providing access to high-quality physicians and a data-driven approach to patient-physician matching, Grand Rounds aims to reduce waste in healthcare spending and facilitate a more efficient and supportive healthcare experience for employees.
Aspire Health, Inc. is a healthcare company based in Nashville, Tennessee, that operates a network of outpatient palliative care practices for patients with serious illnesses. Established in 2012, the company focuses on providing relief from symptoms, pain, and stress associated with conditions such as cancer, congestive heart failure, chronic obstructive pulmonary disease, kidney failure, liver failure, advanced dementia, and amyotrophic lateral sclerosis. Aspire Health supports patients and their caregivers by navigating the healthcare system, aiding in complex treatment decisions, and offering emotional and spiritual guidance. The organization delivers home-based and outpatient clinical services across several Middle Tennessee counties, including Davidson, Robertson, Rutherford, Sumner, Williamson, and Wilson. Aspire Health operates as a subsidiary of Nash Holding Company and emphasizes disease management and care coordination across various settings, including outpatient clinics and assisted living centers.
Private Equity Round in 2014
One Medical is a members-only technology platform offering an array of concierge medical services. The integration of these elements allows them to offer a seamless experience that not only saves their patients time and money but also leads to better health outcomes and happier lives. The company attracts the highest caliber team of health care providers, allowing them to practice medicine the way it should be. Each of their professionals has the time to invest in personal relationships and engage in thoughtful decision-making with their patients. One Medical makes access to care frictionless with face-to-face virtual video visits available anytime. It allows practicing medicine the way it should be practiced, focusing on improving the patient experience, and challenging the healthcare status quo. One Medical was founded in 2007 and is headquartered in San Francisco, California, United States.
HeartFlow is a medical technology company that provides new methods of diagnosis and treatment of cardiovascular disease. It offers HeartFlow Analysis, a non-invasive solution available in the United States, Europe, and Japan that helps a physician evaluate whether a patient has significant coronary artery disease based on anatomy and physiology.
The company was started in 2007 and is based in Redwood City, California.
Eko harnesses the power of smartphones and cloud data for monitoring patients with cardiovascular diseases. It has built a platform of non-invasive cardiovascular monitoring devices, clinical software, and point-of-care decision support algorithms to improve the delivery of cardiovascular care. In 2015, Eko launched the Eko Core Digital Stethoscope, the first FDA-cleared digital stethoscope on the market to wirelessly stream heart and lung sound to HIPAA-compliant software. For the first time in history, patient sounds can be integrated with electronic health records (EHRs) for more seamless referrals, documentation, and monitoring. Eko was established in 2013 and is based in Berkeley, California.